about
Epidemiology and genetics of common mental disorders in the general population: the PEGASUS-Murcia project.Genetics of schizophrenia from a clinicial perspective.Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington diseaseEarly-life stress interactions with the epigenome: potential mechanisms driving vulnerability toward psychiatric illness.Epigenetic mechanisms are involved in the regulation of ethanol consumption in miceBlood transcriptomics of drug-naïve sporadic Parkinson's disease patients.Quantitative comparison of the efficacy of various compounds in lowering intracellular cholesterol levels in Niemann-Pick type C fibroblasts.Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward CircuitryEpigenetics-Based Therapeutics for Neurodegenerative Disorders.Interindividual Variability in Stress Susceptibility: A Role for Epigenetic Mechanisms in PTSD.Bromodomains as therapeutic targets.Epigenetic mechanisms are involved in sexual differentiation of the brain.Epigenetic mechanisms in learned fear: implications for PTSD.Epigenetics components of aging in the central nervous system.Thinking small: towards microRNA-based therapeutics for anxiety disorders.Understanding epigenetic architecture of suicide neurobiology: A critical perspective.Epigenetic Regulation of Infant Neurobehavioral Outcomes.Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies.Alzheimer's Disease and Histone Code Alterations.
P2860
Q30558941-C96E0611-89B1-4585-AC24-4D5E3D2F8FFFQ33729022-AE2734A2-27B8-4216-BC18-F2183F04944DQ33859252-E72F7DC7-C818-4570-AB36-754A0DDA3256Q33874603-D8C96D97-4C5C-45C7-B96F-610FBECBB1D3Q33992088-CAE78C9F-6CCB-4CD8-BC9C-219760CEB7D7Q35203674-D4B505AC-B8FB-4B23-9622-22FF396352C9Q35824982-C07FD50A-F9B7-422E-9674-5C4E61619771Q36353626-541F92E2-1A61-4CF0-AB8A-7F4F355ED216Q36477153-94D12175-4998-422E-B03B-638A430F55DFQ36697733-03009162-697D-4C58-A425-1886181C255FQ36955907-8CB7958A-5630-4E32-BAC2-1C80F156DE6EQ37935915-47AA3930-BB8E-454D-B846-DCD4C1BBA672Q37983392-804EC740-476D-451D-9546-C6FB6F86B613Q38018260-88F7E7F0-538A-433E-A51C-202B3F2732D4Q38153255-4099E98F-C9B6-436D-A042-B66BF59B5784Q38310488-A4E02372-EE67-4F61-A5A0-E190AEA737C0Q39005702-1C31C3F3-C57F-4333-973E-3D5922F0B09AQ39149197-DC1F0C4B-5AA4-468D-836D-1C8A76111400Q48973690-046F68FD-9A0D-4608-B3B7-045B0F203A6FQ50993017-0F138869-BDD7-4C75-9BC7-49DF6DA82079
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pharmacology of epigenetics in brain disorders
@ast
Pharmacology of epigenetics in brain disorders
@en
type
label
Pharmacology of epigenetics in brain disorders
@ast
Pharmacology of epigenetics in brain disorders
@en
prefLabel
Pharmacology of epigenetics in brain disorders
@ast
Pharmacology of epigenetics in brain disorders
@en
P2860
P1476
Pharmacology of epigenetics in brain disorders
@en
P2093
Mike Dragunow
P2860
P304
P356
10.1111/J.1476-5381.2009.00526.X
P407
P577
2009-12-15T00:00:00Z